VRValeria Ramaglia

Valeria Ramaglia

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Valeria Ramaglia has a total of 29 co-authors. Here are the top co-authors by number of shared publications:

  • Frank Baas

    Department of Clinical Genetics, Leiden University Medical Center, Leiden, The Netherlands

    3 shared publications
  • Jeroen J. G. Geurts

    Department of Anatomy and Neurosciences, VU University Medical Center, De Boelelaan 1118, Amsterdam, 1081, The Netherlands

    2 shared publications
  • A Seda Yilmaz-Elis

    Departments of Human Genetics and Immunohematology and Blood Transfusion, Leiden University Medical Center, Albinusdreef 2, 2333 ZA Leiden, The Netherlands

    1 shared publication
  • Birgit Niederreiter

    Department of Rheumatology, Medical University of Vienna, Wien, Vienna, Austria

    1 shared publication
  • Corbert van Eden

    Department of Neuroimmunology, Netherlands Institute for Neuroscience, Amsterdam, The Netherlands

    1 shared publication
  • D. Ramekers

    Department of Genome Analysis, UvA AMC, P.O. Box 22660, 1100 DD Amsterdam, The Netherlands

    1 shared publication

Latest Publications

  • Open Access

    Complement C3 on microglial clusters in multiple sclerosis occur in chronic but not acute disease: Implication for disease pathogenesis

    by Iliana Michailidou, Daphne M. P. Naessens, Simon Hametner, Willemijn Guldenaar, Evert-Jan Kooi, Jeroen J. G. Geurts, Frank Baas, Hans Lassmann, Valeria Ramaglia

    Microglial clusters with C3d deposits are observed in the periplaque of multiple sclerosis (MS) brains and were proposed as early stage of lesion formation. As such they should appear in the brain of MS donors with acute disease but thus far this has not been shown. Using postmortem brain tissue from acute (n = 10) and chronic (n = 15) MS cases we investigated whether C3d+ microglial clusters are part of an acute attack against myelinated axons, which could have implications for disease pathogenesis. The specificity of our findings to MS was tested in ischemic stroke cases (n = 8) with initial or advanced lesions and further analyzed in experimental traumatic brain injury (TBI, n = 26), as both conditions are primarily nondemyelinating but share essential features of neurodegeneration with MS lesions. C3d+ microglial clusters were found in chronic but not acute MS. They were not associated with antibody deposits or terminal complement activation. They were linked to slowly expanding lesions, localized on axons with impaired transport and associated with neuronal C3 production. C3d+ microglial clusters were not specific to MS as they were also found in stroke and experimental TBI. We conclude that C3d+ microglial clusters in MS are not part of an acute attack against myelinated axons. As such it is unlikely that they drive formation of new lesions but could represent a physiological mechanism to remove irreversibly damaged axons in chronic disease. GLIA 2016.


  • Top Cited Papers

    Complement C1q‐C3–associated synaptic changes in multiple sclerosis hippocampus

    by Iliana Michailidou Msc, Janske G. P. Willems, Evert‐Jan Kooi, Corbert van Eden, Stefan M. Gold, Jeroen J. G. Geurts, Frank Baas, Inge Huitinga, Valeria Ramaglia

    Objective: Multiple sclerosis (MS) is a demyelinating disease of the central nervous system, leading to memory impairment in up to 65% of patients. Memory dysfunction in MS has been associated with loss of synapses in the hippocampus, but its molecular basis is unknown. Accumulating evidence suggests that components of the complement system, C1q and C3, can mediate elimination of synapses.Methods: To investigate the involvement of complement in synaptic changes in MS, gene and protein expression and localization of C1q and C3 were analyzed in relation to neuropathological changes in myelinated and demyelinated hippocampi from postmortem MS brains. Findings were compared to hippocampi of Alzheimer disease (AD) and non‐neurological controls.Results: C1q expression and C3 activation were increased in myelinated and demyelinated MS hippocampi, mainly in the CA3/2 and CA1 subfields, which also showed a marked decrease in synaptic density and increased neuronal staining for the mitochondrial heat shock protein 70 (mtHSP70) stress marker. Neurons were the major source of C1q mRNA. C1q protein and activated C3 localized at synapses within human leukocyte antigen–positive cell processes and lysosomes, suggesting engulfment of complement‐tagged synapses by microglia. A significant association (p < 0.0001) between the density of C1q and synaptophysin‐positive synapses or mtHSP70 was seen in myelinated MS hippocampi, further pointing toward a link between the complement pathway and synaptic changes. In contrast to AD, MS hippocampi were consistently negative for the terminal complement activation complex C5b9.Interpretation: These data support a role for the C1q‐C3 complement axis in synaptic alterations in the MS hippocampus. Ann Neurol 2015;77:1007–1026


  • Open Access

    CD55 deposited on synovial collagen fibers protects from immune complex-mediated arthritis

    by Olga N Karpus, Hans P Kiener, Birgit Niederreiter, A Seda Yilmaz-Elis, Jos van der Kaa, Valeria Ramaglia, Ramon Arens, Josef S Smolen, Marina Botto, Paul P Tak, et al.

    Introduction: CD55, a glycosylphosphatidylinositol-anchored, complement-regulating protein (decay-accelerating factor), is expressed by fibroblast-like synoviocytes (FLS) with high local abundance in the intimal lining layer. We here explored the basis and consequences of this uncommon presence. Methods: Synovial tissue, primary FLS cultures, and three-dimensional FLS micromasses were analyzed. CD55 expression was assessed by quantitative polymerase chain reaction (PCR), in situ hybridization, flow cytometry, and immunohistochemistry. Reticular fibers were visualized by Gomori staining and colocalization of CD55 with extracellular matrix (ECM) proteins by confocal microscopy. Membrane-bound CD55 was released from synovial tissue with phospholipase C. Functional consequences of CD55 expression were studied in the K/BxN serum transfer model of arthritis using mice that in addition to CD55 also lack FcγRIIB (CD32), increasing susceptibility for immune complex-mediated pathology. Results: Abundant CD55 expression seen in FLS of the intimal lining layer was associated with linearly oriented reticular fibers and was resistant to phospholipase C treatment. Expression of CD55 colocalized with collagen type I and III as well as with complement C3. A comparable distribution of CD55 was established in three-dimensional micromasses after ≥3 weeks of culture together with the ECM. CD55 deficiency did not enhance K/BxN serum-induced arthritis, but further exaggerated disease activity in Fcgr2b−/− mice. Conclusions: CD55 is produced by FLS and deposited on the local collagen fiber meshwork, where it protects the synovial tissue against immune complex-mediated arthritis.


  • C6 deficiency does not alter intrinsic regeneration speed after peripheral nerve crush injury

    by M. Sta, N.L.M. Cappaert, D. Ramekers, V. Ramaglia, W.J. Wadman, F. Baas